News

Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing, and commercializing products for the critical care market, announced that Stanford University School of Medicine has been activated as the first...

AliveCor, the leader in artificial intelligence and FDA-cleared personal electrocardiogram (ECG) technology, announced new medical research suggesting the use of AliveCor's AI technology as a potential alternative to surgically implanted...

Adm. Brett P. Giroir, MD, assistant secretary for health, announced the release of the U.S. Department of Health and Human Services’ second edition of the Physical Activity Guidelines for Americans at the American Heart Association’s...

For patients who take medication to treat hypothyroidism, being treated with too much medication can lead to an increased risk of atrial fibrillation, a new study has found.

Ventripoint Diagnostics Ltd. is pleased to announce that St. Michael’s Hospital in Toronto, Canada, has ordered the AI-based VMS+ complete heart analysis system for use in clinical evaluations of cardiac patients. Dr. Howard Leong-Poi and Dr....

Itamar Medical Ltd., a company that develops, manufactures, and markets non-invasive diagnostic medical devices for sleep-apnea with a focus on the cardiology market, announced the release of the 2019 Fee Schedule from the U.S. Centers for...

Cardiva Medical, Inc., an innovator in the field of vascular closure, announced that new data from the randomized AMBULATE study will be presented in a late-breaking session on new trials in cardiovascular care at Scientific Sessions 2018,...

Acesion Pharma, a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhythmia, announces positive results from the Phase 1 clinical trial of its lead compound in cardioversion, AP30663....

OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases, announced the closing of a EUR 17 million...

The U.S. Food and Drug Administration is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner, warfarin, that certain test strips used with the devices may provide inaccurate...